Interestingly, PSMA expression in the tumor neovasculature of some solid tumours potentially prevents imaging but also offers potential opportunities for theranostic applications in cancers other than prostate cancer, including colon cancer. This evidence concerns the gene FOLH1 and prostate cancer.